{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T14:29:41Z","timestamp":1780928981077,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00508-016-1133-3","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T02:28:18Z","timestamp":1480559298000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Epidermolysis bullosa House Austria and Epidermolysis bullosa clinical network"],"prefix":"10.1007","volume":"129","author":[{"given":"Martin","family":"Laimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Pohla-Gubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Diem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Prodinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann W","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Hintner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"1133_CR1","unstructured":"Regulation (EC) No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products."},{"key":"1133_CR2","unstructured":"www.orpha.net . Accessed October 10, 2016."},{"key":"1133_CR3","unstructured":"Commission Communication 697 to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases: Europe\u2019s Challenges 11 Nov 2008."},{"key":"1133_CR4","unstructured":"Commission Communication 697 European Council. Council Recommendation on an action in the field of rare diseases (2009\/C 151\/02), 8 June 2009."},{"key":"1133_CR5","unstructured":"http:\/\/www.goeg.at\/de\/NAP_se.html . Accessed October 10, 2016."},{"key":"1133_CR6","doi-asserted-by":"publisher","unstructured":"EUCERD, EUROPLAN. 2009 report on initiatives and incentives in the field of rare diseases of the European Union Committee of experts on rare diseases. In: Aym\u00e9 S, Rodwell C, editors. July 2010. doi: 10.2772\/11801","DOI":"10.2772\/11801"},{"key":"1133_CR7","volume-title":"Recommendations on core indicators for rare disease national plans\/strategies","author":"EUCERD","year":"2013","unstructured":"EUCERD. Recommendations on core indicators for rare disease national plans\/strategies. 6 June. 2013."},{"key":"1133_CR8","volume-title":"Recommendations for quality criteria for centres of expertise for rare diseases in member states","author":"EUCERD","year":"2011","unstructured":"EUCERD. Recommendations for quality criteria for centres of expertise for rare diseases in member states. 24 October. 2011."},{"key":"1133_CR9","volume-title":"Recommendations on rare diseases european reference networks","author":"EUCERD","year":"2013","unstructured":"EUCERD. Recommendations on rare diseases european reference networks. 31 January. 2013."},{"key":"1133_CR10","volume-title":"Life with Epidermolysis Bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy","year":"2008","unstructured":"Fine JD, Hintner H. (editors) Life with Epidermolysis Bullosa (EB): etiology, diagnosis, multidisciplinary care and therapy. Wien: Springer; 2008."},{"key":"1133_CR11","unstructured":"High Level Group, Article 15 of the proposal of Directive of the European Parliament and of the Council on the application of patients\u2019 rights in cross-border healthcare (COM(2008)414; Regulation (EC) No 883\/2004)"},{"key":"1133_CR12","unstructured":"EU rare diseases Task Force. Report to the High Level Group \u2018Contribution to policy shaping: For a\u00a0European collaboration on health services and medical care in the field of RD. 2006."},{"key":"1133_CR13","unstructured":"www.europlanproject.eu . Accessed October 10, 2016."},{"issue":"6","key":"1133_CR14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Banerji A, Bracho F, et al. Icatibant, a\u00a0new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med. 2010;363(6):532\u201341.","journal-title":"N Engl J Med"},{"issue":"12","key":"1133_CR15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1056\/NEJMoa0905360","volume":"361","author":"DD Hoff Von","year":"2009","unstructured":"Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361(12):1164\u201372.","journal-title":"N Engl J Med"},{"key":"1133_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1750-1172-8-69","volume":"8","author":"V Wally","year":"2013","unstructured":"Wally V, Kitzmueller S, Lagler F, et\u00a0al. Topical diacerein for epidermolysis bullosa: a\u00a0randomized controlled pilot study. Orphanet J Rare Dis. 2013;8:69. doi: 10.1186\/1750-1172-8-69 .","journal-title":"Orphanet J Rare Dis"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-016-1133-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-016-1133-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-016-1133-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:57:25Z","timestamp":1498352245000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-016-1133-3"}},"subtitle":["Example of a centre of expertise implemented in a European reference network to face the burden of a rare disease"],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1133"],"URL":"https:\/\/doi.org\/10.1007\/s00508-016-1133-3","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}